26
Fri, May
11 New Articles

B. Braun,  In an effort to meet industry demands for expanded Cephalosporin offerings delivered to patients through safe and accurate administration, B. Braun Medical Inc. (B. Braun) announced that FDA-approved 1g and 2g Cefepime for Injection USP and Dextrose Injection USP in B. Braun Medical Inc.’s DUPLEX® Drug Delivery System will be available for purchase beginning today.

Cumberland Pharmaceuticals Inc. announced the publication of data affirming the safety and efficacy of Caldolor(R) (ibuprofen) Injection in treating fever in critically ill and non-critically ill adults. Published in the peer-reviewed journal Critical Care, the study showed that IV ibuprofen was significantly more effective at reducing fever in hospitalized patients than placebo.

Sign up via our free email subscription service to receive notifications when new information is available.
captcha